Fundraising Fox
Find your path to Francesco
49 people in our graph can introduce you to Francesco.
Sign up to see every warm intro you have to Francesco
- Paths you didn't know you had: your email and LinkedIn already hold routes to Francesco. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Francesco De Rubertis pioneered an asset-centric biotech model that builds companies around a few drug assets and scaled it by assembling Centessa Pharmaceuticals as a company-of-companies aggregating asset-centric subsidiaries.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- Medicxipartnercurrent2016 — present
Deals · 2
Rivus Pharmaceuticals, Inc.Board seat
via Medicxi · filed Jan 2025 · $57M raise
Minerva NeurosciencesBoard seat
via Medicxi · filed Mar 2015 · $31M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Aldena TherapeuticsAlys PharmaceuticalsD3 BioLeviceptOttimo PharmaRivus PharmaceuticalsTOAD Oncology
Investor
CellZomeCentessa PharmaceuticalsGenMabGenSight BiologicsKaerus BiosciencesMicrometMolecular PartnersPanGeneticsParallele BiosciencesProfibrixVaxcyteVersartis
Sources: the firm's website · SEC Form D filings.
Colleagues at Medicxi
Frequently asked questions
- Who is Francesco De Rubertis?
- Francesco De Rubertis pioneered an asset-centric biotech model that builds companies around a few drug assets and scaled it by assembling Centessa Pharmaceuticals as a company-of-companies aggregating asset-centric subsidiaries.
- Where does Francesco De Rubertis work?
- Francesco De Rubertis is Co-founder and Partner at Medicxi.
- What does Francesco De Rubertis invest in?
- Francesco De Rubertis invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Francesco De Rubertis sit on?
- Francesco De Rubertis holds tracked board seats at Aldena Therapeutics, Alys Pharmaceuticals, D3 Bio, Levicept, Minerva Neurosciences, Ottimo Pharma, Rivus Pharmaceuticals, Rivus Pharmaceuticals, Inc., TOAD Oncology.
- What companies has Francesco De Rubertis invested in?
- Investments tracked here include CellZome, Centessa Pharmaceuticals, GenMab, GenSight Biologics, Kaerus Biosciences, Micromet, Molecular Partners, PanGenetics, Parallele Biosciences, Profibrix, Vaxcyte, Versartis.